Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $612.85 | Total: $3,064.25 |
| 1 | 10 | $519.12 | Total: $5,191.20 |
| 1 | 25 | $439.81 | Total: $10,995.26 |
| 1 | 50 | $374.92 | Total: $18,746.00 |
| 1 | 100 | $324.45 | Total: $32,445.01 |
Overview
CNS-5161 hydrochloride (CNS 5161A) is a new antagonist of NMDA ion-channel. It interacts with the NMDA receptorion channel site to produce a noncompetitive blockade of the actions of glutamate.
Chemical Properties
| Molecular Formula | C16H19Cl2N3S2 |
| Molecular Weight | 388.38 |
| CAS Numbers | 160756-38-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | Cl.ClC1=CC=C(SC)C=C1NC(=N)N(C=2C=CC=C(SC)C2)C |
Storage and Handling
0C Short Term, -20C Long Term
References
Walters MR, et al. Early clinical experience with the novel NMDA receptor antagonist CNS 516Br J Clin Pharmacol. 2002 Mar;53[3] 305-11.